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Piper  angustifolium  Lam.,  Piperaceae,  popularly  known  as  “matito”,  “pimenta-de-macaco”,  “pimenta-
longa”  or “jagurandi”  in Brazil,  has been  commonly  used  in the  treatment  of  cutaneous
leishmaniasis-associated  lesions,  but  there  are  few  studies  on  the  activity  against  visceral  leishmaniasis-
associated  species.  This  study  demonstrates  the ﬁrst in  vitro  antileishmanial  activity  of the  P.  angustifolium
essential  oil,  of which  the  phytochemical  proﬁle  showed  the  presence  of sesquiterpenes  and  monoter-
penes.  The  main  compounds  were spathulenol  (23.8%)  and caryophyllene  oxide  (13.1%). P.  angustifolium
essential  oil  was  highly  active  [the half  maximum  inhibitory  concentration  = 1.43 g/ml]  against  intra-
cellular  amastigotes  of  Leishmania  infantum,  the  etiological  agent  of visceral  leishmaniasis  in the  New  and
Old World.  Activity  was  obtained  24  h after  addition  of the  oil  (6.25–50  g/ml),  with  a reduction  of  100%
in  the infection  index  at concentrations  of  25  and  50 g/ml.  P.  angustifolium  essential  oil showed  low
cytotoxicity  for mammalian  ﬁbroblasts  and  macrophages  (the half maximum  inhibitory  concentration
values  of  31.67  and 48.22  g/ml,  respectively),  and  it was  33  and  22  times  more  toxic  to amastigotes  than
to  mammalian  cells,  as indicated  by selectivity  indexes.  The  results  demonstrated  that  P.  angustifolium
essential  oil  is  a promising  alternative  for  the study  of potential  drugs  for visceral  leishmaniasis.
©  2015  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Visceral leishmaniasis (VL) is a severe systemic chronic dis-
ase caused by the Leishmania donovani complex in East Africa
nd the Indian subcontinent, and Leishmania infantum in Europe,
orthern Africa and Latin America (Lukes et al.,  2007). It is one of
he most important neglected diseases today, given its high inci-
ence and mortality, especially among untreated individuals and
alnourished children. It is also considered a disease emerging
n immunocompromised individuals (Jarvis and Lockwood, 2013).
ven during treatment, a case-fatality ratio of 10–20% is estimated
Collin et al., 2004).
The ﬁrst choice drugs in the treatment of leishmaniasis are
he pentavalent antimonials (WHO, 2010). These drugs, however,
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102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editorapresent signiﬁcant limitations concerning their therapeutic safety
as they have a high level of toxicity. High frequency of adverse
effects and teratogenic risk have been described (Miranda et al.,
2006). Lipid formulations of amphotericin B, miltefosine and paro-
momycin have been approved, but the correct dose and efﬁcacy of
these drugs have not been proven in all endemic areas of the dis-
ease (WHO, 2010). Combinations of these drugs have been required
in the cases of infections resistant to antimony (Seifert and Croft,
2006). Considering the scenario of resistance to the main drugs in
use, researchers have been studying new, less toxic drugs, with
greater availability and within reach of the underprivileged popula-
tion affected by the disease (Freitas-Junior et al., 2012). In the search
for new and better compounds, products of plant origin have been
tested since they are easily obtained at low cost (Li and Vederas,
2009).
Piper is one of the genera of great ecological and economic
importance within the Piperaceae family (Monzote et al.,  2010).
Several classes of compounds have been isolated from Piper species,
 Ltda. All rights reserved.
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calculated as described by Monks et al. (1991). The IC50 was  deter-L.S.S. Bosquiroli et al. / Revista Brasile
ncluding those with antileishmanial activity such as benzoic acids
Flores et al., 2007, 2009), dillapiole (Parise-Filho et al., 2012),
nd adunchalcone (Dal Picolo et al., 2014). Moreover, in recent
ears its essential oils have become an important target in the
earch for new therapeutic options against parasites (Antony et al.,
005).
Piper angustifolium Lam. (sin. = Piper aduncum L.), popularly
nown as “matito”, “pimenta-de-macaco”, “pimenta-longa” or
jagurandi” in Brazil, is a plant native to tropical regions such as
he South and Central Americas, Asia, and the Paciﬁc Ocean islands
Martínez et al., 2003). Its leaves are used in folk medicine for
he treatment of stomatitis, vaginitis, erysipelas and liver disor-
ers (Lorenzi and Matos, 2002) or as an antiseptic, antidiarrheal,
onic, astringent, and antirheumatic medicine, and also as an insect
epellent (Schaus and Desmarchelier, 2000). In addition, it has
een commonly used in the treatment of cutaneous leishmaniasis-
ssociated lesions (Martínez et al., 2003), which motivated the
evelopment of some works on Leishmania species associated with
his clinical form of the disease (Braga et al., 2007). In contrast, few
tudies have been conducted on the activity against LV-associated
pecies and up to now, there has been no research on the essential
il extracted from this plant. Thus, the aim of this study was  to char-
cterize the chemical composition of the P. angustifolium essential
il (PAEO) and evaluate its activity against L. infantum.
aterials and methods
lant material
Piper angustifolium Lam., Piperaceae, was collected in January
014 from the Abobral Subregion of the Pantanal of Mato Grosso
o Sul. After the identiﬁcation performed by Dr. Geraldo Alves Dam-
sceno Junior, a botanical voucher was deposited in the herbarium
f Campo Grande/MS, Brazil, under number 20182.
xtraction and analysis of the essential oil
The P. angustifolium essential oil (PAEO) was extracted from the
lant leaves by distillation in a Clevenger apparatus (Vidrolex). The
il was dried with anhydrous sodium sulfate (Vetec, Rio de Janeiro,
razil) with yield of 0.41% (w/w), and stored at −5 ◦C in a sealed
ontainer until the time of analysis. The chemical composition was
etermined by gas chromatography–mass spectrometry (GC–MS)
sing a Shimadzu QP2010 Plus system with a RTX5MS capillary col-
mn  (30 m × 0.25 mm × 0.25 m).  Nitrogen was applied as carrier
as using a ﬂow rate of 1.13 ml/min. The constituents were con-
rmed by comparison with libraries and calculation of the Kovats
ndex.
arasites
The standard strain MHOM/BR/1972/BH46 of L. (Leishmania)
nfantum was used for in vitro assays of antileishmanial activity.
he amastigotes were routinely isolated from Golden hamsters
Mesocricetus auratus) and maintained as promastigotes in Schnei-
er’s Insect Medium (Sigma) supplemented with 20% fetal bovine
erum (FBS, Sigma) and 140 g/ml gentamicin (Sigma) at 26 ◦C. On
he 7th day of cultivation, promastigotes from up to three serial
assages after isolation were used in the experiments.
nimalsBALB/c mice aged six weeks were used to obtain the peritoneal
ells used in the antileishmanial activity assays. The animals were
btained from the central animal facility of the Center for Biolog-
cal and Health Sciences (CCBS) of the Federal University of Mato Farmacognosia 25 (2015) 124–128 125
Grosso do Sul (UFMS, Brazil) in good health and free of infections
or parasites common to rodents, maintained in individually venti-
lated cages equipped with mini-isolators, and fed a balanced feed
(Nuvilab CR-1, Nuvital®) with free access to water. The study was
approved by the Ethics Committee on Animal Use – CEUA/UFMS,
under protocol 432/2012.
Activity against intracellular amastigotes of L. infantum
Peritoneal macrophages from BALB/c mice were isolated after
rinsing with RPMI 1640 medium (Sigma) and placed in a 24-well
plate (1 × 105 cells/well) in RPMI 1640 medium (Sigma) supple-
mented with 10% FCS (Cultilab) and 140 g/ml gentamicin (Sigma).
After incubation at 37 ◦C for 1 h, cells were infected with L. infantum
promastigotes (1 × 106 cells/well) and incubated at 35 ◦C for 4 h.
PAEO was added at concentrations of 6.25–50 g/ml in sets of sex-
tuplicate experiments. Untreated infected cells and amphotericin
B (Sigma) were used as negative and positive control, respectively.
The cells were incubated at 37 ◦C in 5% CO2, ﬁxed and stained with
Giemsa after 24 h. The percentage of infected macrophages and the
total number of amastigotes were determined by counting 200 cells
sixfold. The infection index was determined by multiplying the per-
centage of macrophages that had at least one intracellular parasite
by the mean number of amastigotes per macrophage, as described
by Paladi et al. (2012). A nonlinear dose–response regression curve
was used to calculate the half maximum inhibitory concentration
(IC50). The results were expressed as the mean ± standard devia-
tion (SD) and the data were analyzed using the Student’s t-test.
Differences were considered signiﬁcant at p < 0.05 (represented by
an asterisk).
Nitric oxide (NO) evaluation
To evaluate the production of NO by the infected periton-
eal cells, supernatants of the aforementioned cultures (100 l)
were collected after 24 h of treatment and incubated with an
equal volume of Griess Reagent (1% sulfanilamide/0.1% (naph-
thyl)ethylenediamine in 5% phosphoric acid) at room temperature
for 10 min. The accumulation of nitrite was quantiﬁed accord-
ing to Ding et al. (1988) and the absorbance was determined at
540 nm.  Absorbance was converted to M of NO2− by comparing
the samples with a standard curve obtained with known con-
centrations (1–10 M)  of sodium nitrite diluted in RPMI medium.
The results were expressed as the mean ± standard deviation (SD).
The data were analyzed using the Student’s t-test and differ-
ences were considered signiﬁcant at p < 0.05 (represented by an
asterisk).
Cytotoxicity assay
Fibroblast (NIH/3T3) and murine macrophage (J774.A1) cells
purchased from the Rio de Janeiro Cell Bank (Brazil) were treated
with PAEO at concentrations of 0.25–250 g/ml in triplicate to
estimate IC50. PAEO was dissolved in DMSO (dimethyl sulfoxide
sodium) and diluted in complete medium (the highest concentra-
tion of DMSO used in the test was  0.25%, and did not affect cell
viability). Cells in culture medium were used as negative control
and amphotericin B (0.025–25 g/ml) as positive control. Cell via-
bility was  determined using the sulforhodamine B assay (Skehan
et al., 1990). The percentage of growth of each test sample wasmined by nonlinear regression (Microcal Origin Version 6.0 and
Microsoft Ofﬁce Excel 2007). Selectivity index (SI) was  calculated
by the following formula: IC50 on mammalian cells/IC50 on amastig-
otes (Tiuman et al., 2005).
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Table 1
Chemical constitution of the essential oil from Piper angustifolium.
Compound % Retention time Theoretical KI Calculated KI
1 -pinene 5.87 4.64 939 932
2  camphene 0.53 5.05 946 947
3  cymene 2.77 7.10 1025 1032
4  limonene 4.27 7.20 1032 1037
5  limonene oxide 0.64 8.50 1137 1103
6  cis-verbenol 0.32 8.62 1135 1113
7  cryptone 1.75 9.67 1186 1193
8  cuminaldehyde 1.29 10.24 1242 1249
9  p-cymen-7-ol 0.70 10.71 1291 1297
10  -elemene 1.11 11.14 1339 1339
11  -copaene 0.44 11.55 1393 1388
12  -elemene 4.01 11.68 1389 1402
13  trans-caryophyllene 2.24 12.04 1444 1437
14  aromadendrene 1.80 12.25 1469 1455
15  longifolene 4.5 12.59 1487 1405
16  -muurolene 3.56 12.91 1512 1500
17  -cadinene 3.74 13.13 1534 1526
18  cis-calamenene 0.50 13.24 1543 1535
19  nerolidol 5.80 13.63 1562 1561
20  isospathulenol 1.67 14.04 1589 1630
21  spathulenol 23.78 14.15 1578 1598
22  caryophyllene oxide 13.06 14.28 1613 1605
23  viridiﬂorol 0.51 14.41 1620 1610
24  torreyol 3.81 15.24 1643 1651
15.52 1656 1665
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Fig. 1. Antileishmanial activity of PAEO on L. infantum intracellular amastigotes.25  -cadinol 4.37
I, Kovats index.
esults and discussion
Twenty-ﬁve constituents were identiﬁed in the essential oil
rom P. angustifolium, representing 93.04% of the total com-
ounds. The majority of these were sesquiterpenes and the two
ajor compounds identiﬁed, spathulenol and caryophyllene oxide,
orresponded to 36.8% of the total compounds (Table 1). The phyto-
hemical proﬁle of PAEO differed from that found by Almeida et al.
2009), who observed the predominance of a phenylpropanoid (dil-
apiole – 86.9%) in the essential oil from the aerial parts of the plant
ollected in Pará, Brazil. Parise-Filho et al. (2012) also found dil-
apiole as the major compound of essential oil from the leaves of
he same plant collected in São Paulo, Brazil. Tirillini et al. (1996),
ho collected the same plant in Peru, near Cuzco, observed the
onoterpenes camphor (25.3%) and camphene (22.4%) to be the
ain constituents.
The antileishmanial activity of several sesquiterpenes has been
escribed in the literature (Mikus et al., 2000; Santos et al., 2008;
rruda et al., 2005). Valadeau et al. (2009) demonstrated the activ-
ty of sesquiterpene-rich ethanolic extract from Piper dennisii;
onzote et al. (2010) found an IC50 of 22.3 g/ml for the essential
il from P. auritum against L. donovani amastigotes. The methanolic
ugenol-rich extract from Piper betle was active against L. donovani
mastigotes and promastigotes (Misra et al., 2009). Other sesquiter-
enes with leishmanicidal activity have previously been reported,
s shown by Marques et al. (2011), who identiﬁed E-nerolidol in the
ssential oil from Piper claussenianum (83%). When tested against
eishmania amazonensis arginase, it showed an enzyme inhibition
f 62.2%. Oliveira et al. (2014) tested the essential oil from Boca-
eopsis multiﬂora with 16.2% of spathulenol against L. amazonensis
romastigotes.
This study presents the ﬁrst description of anti-L. infantum activ-
ty associated with the essential oil obtained from P. angustifolium.
ur results demonstrated a dose-dependent increase in the inhi-
ition of the intracellular amastigote proliferation 24 h after the
il was added to infected cells. The infection index decreased, in
 range from 88.1 to 100% from the lowest to the highest concen-
ration, in comparison with untreated infected cells (Fig. 1). The IC
hat reduced 50% of the intracellular forms of L. infantum (IC50)Bars represent the mean ± SD of sextuplicates. *p < 0.01, for the different concentra-
tions compared to untreated cells (control) (Student’s t-test).
was 1.43 g/ml with low cytotoxicity to mammalian cells com-
pared with amphotericin B (Table 2). With regard to SI, PAEO was
33 and 22 times more cytotoxic to intracellular amastigotes than to
NIH/3T3 and J774.A1 cells, respectively (Table 2). Although ampho-
tericin B was  about four times more active than PAEO, this reference
drug was not as selective as the oil, since it was  more cytotoxic to
mammalian cells (Table 2).
Activation of macrophages was  investigated by NO release
(Fig. 2). A signiﬁcant increase (p < 0.05) in NO release was found
after treatment with PAEO at concentrations of 6.25 and 12.5 g/ml,
suggesting that its activity may be associated with this antileishma-
nial mechanism (Stenger et al., 1994). At concentrations of 25 and
50 g/ml, however, PAEO did not induce a signiﬁcant increase in
NO release, showing an atypical result that may  be due to the pres-
ence of certain compounds in the oil. The literature has reported
several compounds inducing this biphasic response (Nothnick and
Soloway, 1998; O’Flaherty et al., 1989, 1990; Adedapo et al., 2009;
Linner et al., 1993; Calabrese, 2005).
Natural products are an important source in the search for new
therapeutic options. The antileishmanial activity of PAEO, coupled
with low cytotoxicity to mammalian cells, makes it a promising
natural product for the development of new drugs for the treatment
of leishmaniases, especially the VL.
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Table  2
Effect of PAEO on intracellular amastigotes of Leishmania infantum, cytotoxicity to mammalian cells and corresponding selectivity index (SI).
Test samples Intracellular amastigotes NIH/3T3 J774.A1
IC50 (g/ml)a IC50 (g/ml)a SIb IC50 (g/ml)a SIb
PAEO 1.43 48.22 33.72 31.67 22.15
Amphotericin B 0.33 2.19 6.63 4.32 13.09
a IC50, half maximum inhibitory concentration.
b SI, selectivity index: IC50 on mammalian cells/IC50 on intracellular amastigotes.
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Fig. 2. Effect of addition of different concentrations of PAEO on the production
of nitric oxide by peritoneal cells infected with L. infantum. Infected cells with-
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